Media Articles Related to Ortho (Ethinyl Estradiol)
Source: MedicineNet Addison Disease Specialty [2014.01.08]
Title: Orthostatic Hypotension
Category: Diseases and Conditions
Created: 6/11/2009 12:00:00 AM
Last Editorial Review: 1/8/2014 12:00:00 AM
EOS imaging receives FDA clearance for new software dedicated to sagittal balance and posture analysis
Source: Bones / Orthopedics News From Medical News Today [2014.09.19]
EOS imaging, the pioneer in 2D/3D orthopaedic medical imaging, has announced that its next-generation sterEOS 3D imaging software, sterEOS 1.6, has received 510(k) clearance from the U.S.
New application of surgical aid used by bone cancer surgical team
Source: Bones / Orthopedics News From Medical News Today [2014.09.11]
An ortho-oncology team at Dartmouth-Hitchcock Norris Cotton Cancer Center successfully adapted a shoulder surgical aid (the Spider Limb Positioner) to conduct a left hip disarticulation on a melanoma...
Study finds cost-saving effort in health care falls short of goals
Source: Health Insurance / Medical Insurance News From Medical News Today [2014.08.07]
A pilot program intended to implement and test a cost-saving strategy for orthopedic procedures at hospitals in California failed to meet its goals, succumbing to recruitment challenges, regulatory...
Published Studies Related to Ortho (Ethinyl Estradiol)
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90
mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual
and premenstrual syndrome (PMS)... CONCLUSIONS: These data, although not consistent, indicate that continuous LNG/EE
Bond strength of orthodontic light-cured resin-modified glass ionomer cement. [2011.04]
The purpose of this study was to compare the bond strengths and debonded interfaces achieved with light-cured resin-modified glass ionomer cement (RMGIC) and conventional light-cured composite resin. In addition, the effects of acid etching and water contamination were examined... Enamel surfaces, with or without water contamination and with or without acid etching, had the same or a greater bond strength than Transbond.
In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets. [2010.12]
INTRODUCTION: One common negative side effect of orthodontic treatment with fixed appliances is the development of incipient caries lesions around brackets, particularly in patients with poor oral hygiene. Bio-available minerals from cement containing amorphous calcium phosphate (ACP) might facilitate remineralization and inhibit lesion development. Our objective was to compare the potential of ACP-containing resin cement, fluoride varnish, resin sealer, and MI Paste (GC America, Alsip, Ill) under similar in-vitro conditions to prevent incipient caries lesions next to brackets on teeth... CONCLUSIONS: Both light-cured filled resin (Pro-seal) and fluoride varnish (Vanish) might prevent enamel demineralization next to orthodontic brackets exposed to cariogenic conditions, but the observed positive effects of Aegis-Ortho and MI Paste were not significant. Copyright (c) 2010 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.
Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects. [2010.12]
BACKGROUND: Limited orthodontics are shown to be effective in the correction of infrabony defects. Studies have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze-dried bone allograft (DFDBA) to treat infrabony defects. This study aims to compare the clinical efficacy of limited orthodontics combined with EMD/DFDBA in the treatment of 2- or 3-wall infrabony defects... CONCLUSION: Although both treatment modalities were effective in managing 2- or 3-wall infrabony defects, limited orthodontics provided an additional benefit to EMD/DFDBA in 2-wall defects.
Effects of different topical agents on enamel demineralization around orthodontic brackets: an in vivo and in vitro study. [2010.09]
BACKGROUND: The aim of this study was to evaluate the in vivo and in vitro effects of a casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and fluoride containing topical agents in reducing enamel demineralization around orthodontic brackets, and to compare this with a control group... CONCLUSIONS: In vivo and in vitro evaluations indicated that CPP-ACP and fluoride containing agents successfully inhibited caries around orthodontic brackets.
Clinical Trials Related to Ortho (Ethinyl Estradiol)
A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Subjects [Recruiting]
The purpose of this study is to look at how the body processes oral contraceptive (OC),
using Ortho-Cyclen, as a commonly prescribed combination oral contraceptive in healthy
female subjects, and the effect of dulaglutide on how Ortho-Cyclen is processed by the body.
Information about any side effects that may occur will also be collected.
Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) [Recruiting]
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada) [Recruiting]
The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho
Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50
years of age who request oral contraceptive protection. Subjects on a LNG, NGM, or
norethindrone/norethindrone acetate containing oral contraceptive in a 21-day regimen
suffering from hormone withdrawal-associated symptoms such of pelvic pain or headache or
both, and willing to continue OC use but to switch to SH T00658ID or Ortho Tri-Cyclen Lo.
Discontinuation of Orthokeratology on Eyeball Elongation in Myopic Children [Recruiting]
The primary aim of this study is to compare eyeball elongation in existing ortho-k subjects
who stop the treatment with subjects who continue ortho-k lens wear and control subjects
wearing single-vision glasses.
Drug Interaction - Oral Contraceptive [Completed]
The purpose of this study is to administer a combined oral contraceptive containing ethinyl
estradiol and norgestimate with the HIV treatment of efavirenz to healthy females in order to
assess if the concentrations of the oral contraceptives change. The safety of this treatment
regimen will also be studied.